Cancer as a Chronic Disease

[1]  Jong-Hyeon Jeong,et al.  Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  F. Hamdy,et al.  Screening for Prostate Cancer , 2006 .

[3]  D. Matei,et al.  Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer , 2016, British Journal of Cancer.

[4]  K. Pienta,et al.  The biology and treatment of oligometastatic cancer , 2015, Oncotarget.

[5]  Keunchil Park,et al.  Can we define the optimal sequence of epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of epidermal growth factor receptor-mutant nonsmall cell lung cancer? , 2017, Current opinion in oncology.

[6]  S. Rosenberg.  The Development of New Immunotherapies for the Treatment of Cancer Using Interleukin‐2: A Review , 1988, Annals of surgery.

[7]  J. Melo,et al.  Chronic myeloid leukemia: the basis of treatment for tomorrow , 2011, Haematologica.

[8]  Immune Checkpoint Inhibitors: New Insights and Current Place in Cancer Therapy , 2015, Pharmacotherapy.

[9]  Bin Zhao,et al.  Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis , 2018, British Medical Journal.

[10]  Bing Xia,et al.  Cooperation of breast cancer proteins PALB2 and piccolo BRCA2 in stimulating homologous recombination , 2010, Nature Structural &Molecular Biology.

[11]  S. Richards,et al.  Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. , 2008, The New England journal of medicine.